CRSP
CRSP
CH0334081137
CRISPR Therapeutics AG
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
5.16B EUR
5.27B EUR
4.59B EUR
5.03B EUR
Enterprise Value
3.3B EUR
5.76B EUR
4.95B EUR
4.89B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-15.27x
--
--
--
Price to Sales
385.49x
479.26x
4,585.06x
--
Price to Book
2.95x
3.02x
2.53x
2.62x
EV/Revenue
246.16x
524.03x
4,949.39x
--
EV/EBITDA
-6.42x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-4.18%
-7.09%
-9.29%
-6.3%
ende